Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for Mild Alzheimer's Disease.
Biotechnology Company Announces U.S. FDA Grants For Alzheimer's Disease Treatment
Biotechnology Company Announces U.S. FDA…
Biotechnology Company Announces U.S. FDA Grants For Alzheimer's Disease Treatment
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for Mild Alzheimer's Disease.